YH 529

Known as: YH-529, YH529 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-1998
012319961998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
YH529, [1-hydroxy-2-(imidazo [1,2-a] pyridin-3-yl) ethylidene]-bisphosphonic acid monohydrate, is a newly developed third… (More)
Is this relevant?
1998
1998
Thirty-six beagles, 18 months of age, underwent ovariohysterectomy (OHX) or a sham operation. Sham-operated animals were given a… (More)
Is this relevant?
1998
1998
Urinary excretion of deoxypyridinoline (D-Pyr) has been shown to be a useful marker for bone resorption. In this study, we… (More)
Is this relevant?
1997
1997
We demonstrated that administration of a bisphosphonate, YH529, prevents the development of disuse atrophy of the hind limbs… (More)
Is this relevant?
1997
1997
We recently demonstrated that osteopenia induced by rat tail-suspension was associated with an initial increase in bone… (More)
Is this relevant?
1996
1996
Our previous studies demonstrated that tail suspension causes early, transient increases in osteoclastic activity, followed by a… (More)
Is this relevant?